NovoCure Ltd (NVCR)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

13 annual periodsNewest to oldest
2025202420232022202120202019201820172016201520142013
Revenue$655.4M$605.2M$509.3M$537.8M$535.0M$494.4M$351.3M$248.1M$177.0M$82.9M$33.1M$15.5M$10.4M
Gross profit$488.5M$468.0M$381.1M$423.0M$420.2M$387.9M$262.7M$168.0M$121.4M$36.6M$12.5M$5.5M$3.3M
Research & development$224.5M$209.6M$223.1M$206.1M$201.3M$132.0M$79.0M$50.6M$38.1M$41.5M$43.7M$40.4M$34.8M
Operating expenses$642.3M$638.5M$613.9M$512.5M$464.5M$357.5M$263.6M$201.7M$160.7M$151.9M$116.5M$85.6M$67.8M
Operating income−$153.8M−$170.5M−$232.9M−$89.5M−$44.3M$30.4M−$914,000−$33.7M−$39.3M−$115.3M−$104.0M−$80.2M−$64.5M
EBITDAderived−$139.2M−$159.3M−$221.9M−$78.9M−$34.1M$39.6M$7.5M−$24.7M−$31.7M−$109.7M−$100.8M−$78.2M−$63.2M
Net income−$136.2M−$168.6M−$207.0M−$92.5M−$58.4M$19.8M−$7.2M−$63.6M−$61.7M−$131.8M−$111.6M−$80.7M−$77.4M
Basic EPSper diluted share-$1.22-$1.56-$1.95-$0.88-$0.56$0.20-$0.07-$0.69-$0.70-$1.54-$3.67-$6.46-$6.73
Diluted EPSper diluted share-$1.22-$1.56-$1.95-$0.88-$0.56$0.18-$0.07-$0.69-$0.70-$1.54-$3.67-$6.46-$6.73

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys4$1.23M disclosed value
Sells (SEC code S)77$5.59M disclosed value
81 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Jun 4, 2026Form 4Leonard Frank XChief Executive OfficerSellOrdinary Shares34.3K$17.93$614.5K459.5K
Jun 2, 2026Form 4Stafford KristinDirectorSellOrdinary Shares2.9K$15.77$46.4K11.3K
Jun 2, 2026Form 4Ocean Allyson JDirectorSellOrdinary Shares2.9K$15.77$46.4K11.3K
Jun 2, 2026Form 4Scannell Timothy JDirectorSellOrdinary Shares2.9K$15.77$46.4K14.3K
Jun 2, 2026Form 4VERNON W ANTHONYDirectorSellOrdinary Shares2.9K$15.77$46.4K197.7K